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REVIEW OF NATIVE FRAGILE SITES
IN SACCHAROMYCES CEREVISIAE:
A COMPARISON TO
HUMAN FRAGILE SITES
Tayler M. Murphy
Dr. Anne Casper, Mentor
ABSTRACT

Saccharomyces cerevisiae (S. cerevisiae) was the first
eukaryote to have its full genome sequenced, which makes it
one of the longest studied genomes. The scientific community
has established that S. cerevisiae is a useful model in the study
of human diseases due to the homology that exists in numerous
human and yeast genes. Yeast artificial chromosomes (YACs) have
been developed that contain inserts of human DNA. These YACs
can be used to study the mechanisms that cause DNA fragility
in humans by placing a known human fragile site within a YAC.
Though it is useful to study human DNA inserted into yeast to
monitor the inherent fragility of the sequence, studying the nature
of native yeast fragile sites may have benefits as well. The types
of native fragile sites in Saccharomyces cerevisiae include Mec1
mutant, hydroxyurea, palindromic, ty-element, and Pol1 mutant
induced fragile sites. Many of the mechanisms of yeast DNA
fragility are similar to those of human DNA. The purpose of this
review is to compare and contrast the mechanisms of fragility in
S. cerevisiae and human DNA. Though human and yeast fragile
sites are not always caused by similar means, with further study of
the native fragile sites in S. cerevisiae, more similarities may be
found that can give further insight into the human fragile sites and
diseases caused by them.
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INTRODUCTION
Saccharomyces cerevisiae
Saccharomyces cerevisiae (S. cerevisiae), often referred
to as baker’s or budding yeast, is a type of fungi found naturally
on the outside of grapes and figs (Goffeau et al., 1996). The names
“baker’s” and “brewer’s” yeast reflect the ways that S. cerevisiae has
been used for centuries. S. cerevisiae was used to leaven dough and
to produce ethanol through fermentation in brewing. In addition
to being used to make beer and bread, S. cerevisiae has become
common in many research labs due in part to its having been the
first eukaryote to have its full genome sequenced (Goffeau et al.,
1996). As a result, much has been learned about budding yeast,
which coupled with it being an easy organism to grow and work
with, makes it a prevalent model organism (Botstein, Chervitz, &
Cherry, 1997).
Moreover, S. cerevisiae is a unicellular organism, unlike
humans, which are multicellular. However, both organisms are
eukaryotes and as a result many homologous genes, genes that
code for similar traits, have been found, making S. cerevisiae
important in research pertaining to human genetic disease
(Botstein et al., 1997). The existence of homologous genes in
a unicellular organism affords researchers the ability to study
the genes in a less complex organism. These results can then be
applied to better understand the homologous gene in the more
complex organism. Due to varying similarities to mammals,
yeast has been used as models in the study of the effects of
pharmacological molecules (Mattiazzi, Petrovic, & Krizaj, 2012),
neurological diseases (Sarto-Jackson & Tomaska, 2016), energy
metabolism (Zhang, Vermuri, & Nielsen, 2010), and fragile sites
(Lemoine, Degtyareva, Lobachev, & Petes, 2005).

Fragile Sites
A fragile site is an area of a gene that experiences frequent
breaks for any number of reasons. While fragile sites occur in
many organisms, we will focus on fragility in the S. cerevisiae and
human genomes. Yeast fragile sites are not separated into specific
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categories; they are defined by the mechanism that causes the
fragility. Studies have indicated that certain yeast fragile sites
behave similarly to human fragile sites. For example, both
human and yeast fragile sites are susceptible to replication stress
(Raveendranathan et al., 2006). In addition, two kinases in yeast
that play direct roles in fragile site stability, Mec1 and Tel1, are
homologs of human ATR and ATM proteins, respectively (Cha
& Kleckner, 2002). There are instances of breaks due to knockout of Mec1, which mirrors common fragile sites (CFSs; Cha &
Kleckner, 2002).
There are two categories of human fragile sites: “common”
fragile sites and “rare” fragile sites (Durkin & Glover, 2007).
Common fragile sites may occur in the whole population
(Zlotorynski et al., 2003); these fragile sites cluster around areas
of replication stress and occur more frequently than rare fragile
sites (Durkin & Glover, 2007). Many common fragile sites
can be induced by a form of replication stress, including DNA
polymerase inhibitors such as aphidicolin (Glover, Berger, Coylr,
& Echo, 1984). These are of particular interest because they have
been linked to tumorigenesis (Smith, Huang, & Wang, 1998). It
has also been suggested that common fragile sites may be used
to indicate a predisposition to lung cancer (Karadag et al., 2002).
Being linked to such serious diseases warrants further study of
fragile sites, which may lead to a more effective understanding and
prevention of these diseases.

Yeast as a Model for the Study of Fragile Sites

Two methods have been established to study fragile
sites in S. cerevisiae. First, a yeast artificial chromosome (YAC)
containing a fragile human DNA sequence can be placed in the
yeast genome (Wilke et al., 1995). Placing human DNA into yeast
cells is advantageous because it allows the DNA sequence to be
studied out of context. It also allows the human DNA to be studied
in a less complex organism, which can be efficient economically
and practically. To determine if a sequence of human DNA is
inherently fragile, it is vital to remove it from the context of the
human chromosome to reduce variables. Outside the context of
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human cells, we can examine whether the sequence itself is the
cause of fragility, or if it is fragile due to factors that take place within
human cells. Studying YACs is economical and practical because
yeast are easier to reproduce and sustain than human cells.
Moreover, native yeast fragile sites can also be studied.
Due to the similarities, they can provide insights into the causes of
human fragile sites. This review will be discussing yeast native fragile
sites induced by low DNA polymerase α, mec1Δ, Ty elements, DNA
replication defects, and palindromic cruciform structures.

Yeast Native Fragile Sites
Low DNA Polymerase Alpha Induced Fragile Sites

DNA polymerase alpha must be present for yeast to
undergo DNA replication (Lemoine et al., 2005). Adding a
GAL1 promoter to the POL1 gene can allow for the control of
DNA polymerase alpha production. The GAL1 promoter causes
the POL1 gene to be replicated only when galactose is present
(Lemoine et al., 2005). Therefore, when no galactose is present,
the POL1 gene is not replicated and DNA polymerase alpha is
not made (Lemoine et al., 2005). Figure 1. illustrates how media
containing different levels of galactose affect yeast containing
the GALPOL1 gene. The results of this experiment showed that
DNA replication stress induced by low levels of DNA polymerase
alpha caused increased fragility in S. cerevisiae. This included
duplications, deletions, and translocations between Ty elements
(Lemoine et al., 2005).
Similarly, human common fragile sites can be induced by
DNA polymerase alpha inhibitors such as aphidicolin (Glover et al.,
1984). Comparably, induced DNA fragility at common fragile sites
also includes duplications, deletions, and translocation (Zlotorynski
et al., 2003; Kurahashi & Emanuel, 2001). However, these
translocations occur at AT-rich palindromic repeats (Kurahashi &
Emanuel, 2001). Additionally, human CFSs and native yeast fragile
sites are late replicating (Le Beau et al., 1998; Lemoine et al., 2005).
When DNA polymerase alpha is inhibited in both yeast and human
cells it causes sensitivity to DNA damaging molecules, including
hydroxyurea (HU; Lemoine et al., 2005; Zeeland et al., 1982).
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Figure 1.
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In contrast, fragile sites that occur when DNA polymerase
alpha is inhibited cause illegitimate mating in yeast and not humans,
because humans are multicellular complex organisms (Lemoine et
al., 2005). Moreover, in yeast DNA, polymerase alpha was inhibited
using the GAL1 promoter (Lemoine et al., 2005), while it was
inhibited with aphidicolin in humans (Zeeland et al., 1982).

Palindromic Sequence Breaks

DNA fragility can occur at palindromic sequence in
the yeast genome (Nag & Kurst, 1997). A palindromic sequence
is one that when read five-prime (5’) to three-prime (3’) on one
strand is the same as when reading 5’ to 3’ on the complimenting
strand. Because the sequence is a palindrome, when DNA
replication begins and the DNA is temporarily single-stranded,
it can hydrogen bond to itself, causing secondary structures such
as hairpin loops or cruciform (Nag & Kurst, 1997). Figure 2.
illustrates a possible cruciform structure. When DNA is formed
into these structures the cell can resolve it in a number of ways
(Nag & Kurst, 1997). Many resolutions cause double-stranded
breaks during meiosis (Nag & Kurst, 1997). Though this particular
fragile site is not truly native to yeast, it was inserted via a plasmid
vector by which palindromic sequences are thought to occur
(Nag & Kurst, 1997). Deletions occur at palindromic areas of the
human genome (Kurahashi et al., 2009). Unlike these palindromic
sequences in yeast, the palindromic sequences in humans cause
problems during mitosis, not meiosis (Kurahashi et al., 2009).
The fragility of these human palindromic sequences is induced by
replication stress; the sites are not inherently fragile, like the yeast
palindromic sequences (Kurahashi et al., 2009).
In other studies, plasmids containing palindromic
sequences were introduced into Saccharomyces cerevisiae and
were shown to be resolved using mechanisms characteristic of
Holliday junction resolution (Cote & Lewis, 2008). Figure 2.
illustrates a possible cruciform resolution via a Holliday junction
resolution. It is proposed that after resolution leading to one or
more hairpin loops, nuclease Mre11 can remove the hairpin caps
(Cote & Lewis, 2008). Removal of the hairpin caps can allow
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Figure 2. Resolution of Palindromic Sequence as a Holliday Junction. The green sections are
used to represent sections of DNA, which are inverted repeats. These result in hairpin loops
or cruciform structures when single stranded, as they are during replication. After resolution
of the cruciform structure, a break can be formed due to the manner in which it has been
resolved. If it is resolved as a Holliday junction, the palindromic sequences remain hydrogen
bonded. This illustration is only meant to be a visual representation, and is not to scale.
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for repair of the double-strand break (Lobacheb, Gordenin, &
Resnick, 2002). Mre11 is a nuclease also found in mammalian
cells, including humans (Lee & Paull, 2005).
As stated previously, human DNA also contains palindromic
regions (Zlotorynski et al., 2003). However, these palindromes are
usually AT-rich, and the sequence inserted into the yeast cell is not
(Zlotorynski et al. 2003; Nag & Kurst, 1997). Furthermore, the ATrich sequences in humans form hairpin loops, opposed to cruciform
structures (Zlotorynski et al. 2003; Nag & Kurst, 1997).

Mutant Mec1 Linked Fragile Sites
Mec1 has been shown to play an important role in the
prevention of DNA breaks at replication slow zones (RSZ)
in yeast (Cha & Kleckner, 2002). During DNA replication
in S-phase, effective replication of DNA requires dNTPs to
be present. These dNTPs are synthesized in part by Rnr1 a
ribonucleotide reductase. Rnr1 is inhibited by Sml1, which
causes lower levels of dNTPs to be present. Lower levels
of dNTPs can cause replication problems in RSZs (Cha &
Kleckner, 2002). Through its downstream target Rad53, Mec1
inhibits Sml1, which allows Rnr1 to produce dNTPs. Having
enough dNTPs lowers the formation of double strand breaks
(DSBs) at RSZs. However, when Mec1 is replaced with mec1ts, a thermosensitive gene, double strand breaks occur at RSZs
under restrictive temperatures (Cha & Kleckner. 2002). Under
these temperature sensitive conditions, it has been found
that knocking out Rrm3 decreases DSBs at RSZs (Hashash,
Johnson, & Cha, 2011). This occurs because rr3Δ leads to Sml1
degradation (Hashash et al., 2011). To support the hypothesis
that RSZs are fragile because of low dNTP concentration, mec1ts cells were treated with hydroxyurea (Hashash et al., 2011).
Hydroxyurea (HU) inhibits Rnr1, which causes dNTPs to not
be up regulated. In mec1-ts cells that were treated with HU,
more breaks occurred at RSZs (Hashash et al., 2011). However,
when exposed to excessively high concentrations of HU, fewer
breaks occurred at RSZs because the replication forks collapsed
before the RSZs could be reached (Hashash et al., 2011).
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To further understand S-phase checkpoint kinases, Mec1
and Rad53 mutants mec1-1 and rad53-1 were introduced in yeast
(Raveendranathan et al., 2006). These mutant genes prevent the
Mec1 and Rad53 kinases from being produced (Raveendranathan
et al., 2006). Yeast cells that do not produce Mec1 and Rad53
exhibited hindered DNA replication due to replication fork
collapse (Raveendranathan et al., 2006). A cascade of events linked
to Mec1 causes the production of dNTPs, which are required for
DNA replication, and when these are in limited supply due to
the mec1-1 or rad53-1 mutation, replication slow zones were the
result (Raveendranathan et al., 2006).
In addition, it has been shown that Mec1 and Tel1 activity
in response to DNA damage causes phosphorylation of histone
H2A, resulting in γ-H2AX (Szilard et al., 2011). Searching for and
mapping γ-H2AX allows for the identification of many fragile sites
on the yeast genome (Szilard et al., 2011). A homologous pathway
occurs in human cells. Mec1 homolog ATR and Tel1 homolog ATM
respond to DNA damage, and this leads to the phosphorylation
of histone H2A, which results in γ-H2A, as shown in Figure 3.
(Szilard et al., 2011).
In addition to the similarities between yeast and human
phosphorylation of histones, the human homolog of MEC1,
ATR, is also involved in a replication checkpoint (Wan, Kulkami,
&Wang, 2010). ATR and MEC1 are both needed in response
to DNA polymerase alpha inhibition (Wan et al., 2010; Song,
Dominska, Greenwell, & Petes, 2014). ATR and MEC1 are also
both involved in a pathway with ribonucleotide reductases
(Zhang, Jones, Martin, Caplen, & Pommier, 2009; Cha &
Kleckner, 2002).

Hydroxyurea Induced Fragile Sites
To study the effects of hydroxyurea (HU) induced
replication stress, Feng, Di Rienzi, Raghuraman, and Brewer
(2011) subjected yeast DNA to HU and used ssDNA detection to
monitor replication fork movement. After HU exposure they were
able to map breaks in the chromosome, which clustered around
areas containing replication forks (Feng et al., 2011). Additionally,
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Figure 3. Flow Chart Highlighting the Pathway from Mec1 to dNTP Production.
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single-stranded DNA (ssDNA) was found before chromosome
breaks were observed, indicating that ssDNA may be involved in
the development of double-strand breaks (Feng et al., 2011). A
specialized yeast strain containing mec1-4, which is temperature
sensitive and which was not subjected to HU, was also shown to
have ssDNA preceding chromosome breaks (Feng et al., 2011).
This further supports the hypothesis that ssDNA is involved in
chromosome breakage. The proposed cause of ssDNA in this study
is uncoupled DNA synthesis or cutting of already synthesized
DNA (Feng et al., 2011).
Similarly, HU can cause replication stress in human cells,
which leads to ssDNA (Mortusewicz, Evers, & Helleday, 2016).
Double-strand DNA breaks in human cells also occur at ssDNA
(Mortusewicz et al., 2016). Humans have an ssDNA-binding
protein that stabilizes sites of replication that can be stalled due to
hydroxyurea (Mortusewicz et al., 2016).

CONCLUSIONS
The similarities between the genome of Saccharomyces
cerevisiae and the human genome allows us to study fragile
sites in yeast and apply this knowledge to human fragile sites.
Many of the mechanisms that cause native yeast fragile sites also
cause human fragile sites. In many cases, homologous genes are
involved in similar pathways. These homologous genes are the
similarities left over from the common ancestor of yeast and
humans. Because the yeast genome is much smaller and yeast
are easier to work with than human cells, yeast will continue to
be an important model organism for studying fragile sites. Even
after we have exhausted the similarities between them, yeast
can still be used to study human fragile sites out of context by
placing human DNA in the yeast genome. The discoveries to
be made by studying fragile sites in yeast are many, and they
will likely help to establish treatments for diseases linked to
fragile sites, as well as to establish mechanisms for mapping
fragile sites on chromosomes.
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